Evaluating land use and management Natural Flood Management potential

Soil use and management as a form of Natural Flood Management (NFM) has potential to increase infiltration and soil water storage above and below ground. As a result, it can slow the flow of water and reduce flooding caused by surface run-off, rivers and groundwater. Here, we report findings from the LANDWISE project, which examined the potential of land use and management in lowland groundwater-fed catchments in the River Thames Basin, England. We focused on five soil classes within two geology types: shallow permeable soils on carbonate geology (Limestone and Chalk) and deep clay soils on mudstone geology; across agricultural land, grassland and woodland. We compared different farming systems, including conventional, innovative and organic agriculture. We gathered empirical evidence of within and between field variation for different soil use and management strategies, through a broad survey of 164 fields and an in-depth survey of 7 sites. We show that both land use and soil type are significant in affecting bulk density. We also show correlation between organic matter and bulk density, which is important for NFM as organic matter content can be controlled by land use and management practices. We adopted a co-production research approach, to deliver usable impacts for farmers who will ultimately deliver NFM through land use change and management. This work will inform policy and design and delivery of agri-environment schemes; such as the soil survey scheme, a key part of the DEFRA soil action plan. It will help co-deliver NFM alongside other ecosystem services

Beyond altruism: British football and charity, 1877-1914

Football charity matches and tournaments played a significant part in the development of the sport in Britain, overlapping the era of friendly games and the advent of competitive leagues. The football community prided itself on its contributions to charity, raising more money than any other sport before 1914, and stakeholders within the game – associations, clubs, players and patrons – gained considerable kudos for this perceived altruism. However, this paper will demonstrate that amounts donated, though welcome, were relatively minor sources of revenue for both institutions and individuals, and that the charity match became less important to clubs in a professional, and increasingly commercial, era

Defining the Critical Hurdles in Cancer Immunotherapy

ABSTRACT: Scientific discoveries that provide strong evidence of antitumor effects in preclinical models often encounter significant delays before being tested in patients with cancer. While some of these delays have a scientific basis, others do not. We need to do better. Innovative strategies need to move into early stage clinical trials as quickly as it is safe, and if successful, these therapies should efficiently obtain regulatory approval and widespread clinical application. In late 2009 and 2010 the Society for Immunotherapy of Cancer (SITC), convened an "Immunotherapy Summit" with representatives from immunotherapy organizations representing Europe, Japan, China and North America to discuss collaborations to improve development and delivery of cancer immunotherapy. One of the concepts raised by SITC and defined as critical by all parties was the need to identify hurdles that impede effective translation of cancer immunotherapy. With consensus on these hurdles, international working groups could be developed to make recommendations vetted by the participating organizations. These recommendations could then be considered by regulatory bodies, governmental and private funding agencies, pharmaceutical companies and academic institutions to facilitate changes necessary to accelerate clinical translation of novel immune-based cancer therapies. The critical hurdles identified by representatives of the collaborating organizations, now organized as the World Immunotherapy Council, are presented and discussed in this report. Some of the identified hurdles impede all investigators, others hinder investigators only in certain regions or institutions or are more relevant to specific types of immunotherapy or first-in-humans studies. Each of these hurdles can significantly delay clinical translation of promising advances in immunotherapy yet be overcome to improve outcomes of patients with cancer

The Cholecystectomy As A Day Case (CAAD) Score: A Validated Score of Preoperative Predictors of Successful Day-Case Cholecystectomy Using the CholeS Data Set

Background Day-case surgery is associated with significant patient and cost benefits. However, only 43% of cholecystectomy patients are discharged home the same day. One hypothesis is day-case cholecystectomy rates, defined as patients discharged the same day as their operation, may be improved by better assessment of patients using standard preoperative variables. Methods Data were extracted from a prospectively collected data set of cholecystectomy patients from 166 UK and Irish hospitals (CholeS). Cholecystectomies performed as elective procedures were divided into main (75%) and validation (25%) data sets. Preoperative predictors were identified, and a risk score of failed day case was devised using multivariate logistic regression. Receiver operating curve analysis was used to validate the score in the validation data set. Results Of the 7426 elective cholecystectomies performed, 49% of these were discharged home the same day. Same-day discharge following cholecystectomy was less likely with older patients (OR 0.18, 95% CI 0.15–0.23), higher ASA scores (OR 0.19, 95% CI 0.15–0.23), complicated cholelithiasis (OR 0.38, 95% CI 0.31 to 0.48), male gender (OR 0.66, 95% CI 0.58–0.74), previous acute gallstone-related admissions (OR 0.54, 95% CI 0.48–0.60) and preoperative endoscopic intervention (OR 0.40, 95% CI 0.34–0.47). The CAAD score was developed using these variables. When applied to the validation subgroup, a CAAD score of ≤5 was associated with 80.8% successful day-case cholecystectomy compared with 19.2% associated with a CAAD score >5 (p < 0.001). Conclusions The CAAD score which utilises data readily available from clinic letters and electronic sources can predict same-day discharges following cholecystectomy